Gut check: Semaglutide's hidden effect on obesity bacteria
NCT ID NCT07323134
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will give 40 obese adults semaglutide for 12 weeks to see how it changes their gut bacteria. Researchers will use stool samples and lab tests to understand the effects. The goal is to learn how semaglutide works on gut flora, not to test weight loss directly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- semaglutide injection
- What this could lead to
- If successful, this could reveal how semaglutide changes gut bacteria, possibly pointing to new ways to treat obesity.
- What could go wrong
- This is a small, early-stage study (40 people) that only looks at gut bacteria changes, not weight loss. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?